Primo Chemicals Ltd Valuation Shifts Signal Changing Market Sentiment

Price Performance Outpaces Benchmarks

On 28 Sep 2026, Primo Chemicals closed at ₹25.27, up 12.86% from the previous close of ₹22.39. The stock’s intraday range was ₹22.75 to ₹25.48, nearing its 52-week high of ₹27.50 and well above its 52-week low of ₹16.21. This sharp price appreciation contrasts markedly with the broader market, as the Sensex declined by 0.54% over the past week and 4.84% over the last month. Year-to-date, Primo Chemicals has delivered a modest 5.5% return, outperforming the Sensex’s negative 13.3% return over the same period.

Longer-term returns reveal a mixed picture. While the stock has underperformed over three and five years, with returns of -57.4% and -0.12% respectively, it has dramatically outpaced the Sensex over a decade, delivering a staggering 672.8% gain compared to the benchmark’s 157.8%. This suggests that while recent years have been challenging, the company’s long-term growth story remains intact in the eyes of investors.

Valuation Metrics Signal Elevated Premium

The recent upgrade in Primo Chemicals’ Mojo Grade from Hold to Buy on 25 Sep 2026 coincides with a shift in valuation grading from fair to expensive. The company’s trailing price-to-earnings (P/E) ratio now stands at 37.91, significantly above the peer average and historical norms for the commodity chemicals sector. For context, peer companies such as J.G. Chemicals trade at a P/E of 32.35 with a fair valuation grade, while others like I G Petrochems and Titan Biotech are classified as very expensive with P/Es of 22.39 and 48.29 respectively.

Primo Chemicals’ price-to-book value (P/BV) ratio is 1.51, indicating a moderate premium over book value but still within a reasonable range for a micro-cap in this sector. However, the enterprise value to EBITDA (EV/EBITDA) multiple of 10.76 is elevated compared to some peers, reflecting the market’s willingness to pay more for earnings before interest, taxes, depreciation and amortisation. This contrasts with J.G. Chemicals’ EV/EBITDA of 23.8 and I G Petrochems’ 9.31, placing Primo Chemicals in a middle ground but leaning towards the expensive side.

Operational Efficiency and Returns Lag Behind

Despite the premium valuation, Primo Chemicals’ operational returns remain subdued. The latest return on capital employed (ROCE) is a modest 2.95%, while return on equity (ROE) stands at 3.83%. These figures are relatively low for the commodity chemicals industry, where efficient capital utilisation and profitability are critical for sustaining growth and justifying higher multiples. The company’s EV to capital employed ratio of 1.39 and EV to sales of 1.32 further underline the cautious stance investors might take given the current profitability metrics.

Peer Comparison Highlights Valuation Divergence

When benchmarked against its industry peers, Primo Chemicals’ valuation stands out as expensive but not extreme. For example, Oriental Aromatics trades at a P/E of 335.14, an outlier in the sector, while companies like Nitta Gelatin and Indo Borax & Chemicals are also rated expensive or very expensive with P/Es below Primo’s but higher EV/EBITDA multiples. This suggests that while Primo Chemicals is priced at a premium, it remains more accessible than some of the sector’s most richly valued stocks.

Interestingly, the PEG ratio for Primo Chemicals is reported as 0.00, which may indicate either a lack of earnings growth data or an anomaly in calculation. In contrast, peers such as J.G. Chemicals and I G Petrochems have PEG ratios of 1.98 and 0.65 respectively, signalling varying expectations of growth relative to price.

Market Capitalisation and Micro-Cap Status

Primo Chemicals is classified as a micro-cap stock, which often entails higher volatility and risk but also potential for outsized returns. The recent upgrade in Mojo Grade to Buy with a score of 71.0 reflects improved market sentiment and technical momentum. This upgrade from Hold suggests that analysts and investors are increasingly confident in the company’s prospects despite the elevated valuation.

Investment Implications and Outlook

Investors considering Primo Chemicals should weigh the stock’s strong recent price momentum and upgraded rating against its stretched valuation multiples and modest profitability metrics. The elevated P/E and EV/EBITDA ratios imply that the market is pricing in future growth or operational improvements that have yet to materialise in the company’s returns on capital.

Given the stock’s micro-cap status and sector dynamics, volatility remains a key risk factor. However, the long-term return of 672.8% over ten years indicates that Primo Chemicals has delivered substantial value to patient investors historically. The current premium valuation may be justified if the company can enhance its operational efficiency and capital returns in the near term.

Conclusion: Valuation Premium Reflects Market Optimism

Primo Chemicals Ltd’s recent valuation upgrade to expensive is a clear indication of shifting market sentiment, driven by robust price gains and an improved Mojo Grade. While the company’s profitability metrics remain modest, the premium multiples suggest investors are anticipating operational improvements or sector tailwinds that could enhance returns going forward.

For investors, the key consideration is whether Primo Chemicals can translate its strong momentum into sustainable earnings growth and capital efficiency. The stock’s micro-cap status and commodity chemicals sector exposure add layers of risk and opportunity that require careful analysis. Ultimately, the elevated valuation demands a cautious but optimistic approach, balancing the potential for upside against the inherent volatility of the segment.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today